The incidence rate of malaria and the ensuing mortality prompts the development of novel antimalarial drugs. In this work, the activity of twenty-eight Amaryllidaceae alkaloids (1-28) belonging to seven different structural types was assessed, as well as twenty semisynthetic derivatives of the β-crinane alkaloid ambelline (28a-28t) and eleven derivatives of the α-crinane alkaloid haemanthamine (29a-29k) against the hepatic stage of Plasmodium infection. Six of these derivatives (28h, 28m, 28n and 28r-28t) were newly synthesized and structurally identified. The most active compounds, 11-O-(3,5-dimethoxybenzoyl)ambelline (28m) and 11-O-(3,4,5-trimethoxybenzoyl)ambelline (28n), displayed IC50 values in the nanomolar range of 48 and 47 nM, respectively. Strikingly, the derivatives of haemanthamine (29) with analogous substituents did not display any significant activity, even though their structures are quite similar. Interestingly, all active derivatives were strictly selective against the hepatic stage of infection, as they did not demonstrate any activity against the blood stage of Plasmodium infection. As the hepatic stage is a bottleneck of the plasmodial infection, liver-selective compounds can be considered crucial for further development of the malaria prophylactics.

Prudêncio Lab Instituto de Medicina Molecular João Lobo Antunes Faculdade de Medicina Universidade de Lisboa Av Prof Egas Moniz Edf Egas Moniz 1649 028 Lisboa Portugal

Secondary Metabolites of Plants as Potential Drugs Research Group Department of Pharmacognosy and Pharmaceutical Botany Faculty of Pharmacy Charles University Heyrovského 1203 500 05 Hradec Králové Czech Republic

000      

00000naa a2200000 a 4500

001      

bmc23002653

003      

CZ-PrNML

005      

20230421100028.0

007      

ta

008      

230413s2023 sz f 000 0|eng||

009      

AR

024    7_

$a 10.3390/pharmaceutics15031007 $2 doi

035    __

$a (PubMed)36986868

040    __

$a ABA008 $b cze $d ABA008 $e AACR2

041    0_

$a eng

044    __

$a sz

100    1_

$a Breiterová, Kateřina Hradiská $u Secondary Metabolites of Plants as Potential Drugs Research Group, Department of Pharmacognosy and Pharmaceutical Botany, Faculty of Pharmacy, Charles University, Heyrovského 1203, 500 05 Hradec Králové, Czech Republic $1 https://orcid.org/0000000347845601 $7 uk20201096119

245    10

$a Derivatives of Amaryllidaceae Alkaloid Ambelline as Selective Inhibitors of Hepatic Stage of Plasmodium berghei Infection In Vitro / $c KH. Breiterová, A. Ritomská, D. Fontinha, J. Křoustková, D. Suchánková, A. Hošťálková, M. Šafratová, E. Kohelová, R. Peřinová, R. Vrabec, D. Francisco, M. Prudêncio, L. Cahlíková

520    9_

$a The incidence rate of malaria and the ensuing mortality prompts the development of novel antimalarial drugs. In this work, the activity of twenty-eight Amaryllidaceae alkaloids (1-28) belonging to seven different structural types was assessed, as well as twenty semisynthetic derivatives of the β-crinane alkaloid ambelline (28a-28t) and eleven derivatives of the α-crinane alkaloid haemanthamine (29a-29k) against the hepatic stage of Plasmodium infection. Six of these derivatives (28h, 28m, 28n and 28r-28t) were newly synthesized and structurally identified. The most active compounds, 11-O-(3,5-dimethoxybenzoyl)ambelline (28m) and 11-O-(3,4,5-trimethoxybenzoyl)ambelline (28n), displayed IC50 values in the nanomolar range of 48 and 47 nM, respectively. Strikingly, the derivatives of haemanthamine (29) with analogous substituents did not display any significant activity, even though their structures are quite similar. Interestingly, all active derivatives were strictly selective against the hepatic stage of infection, as they did not demonstrate any activity against the blood stage of Plasmodium infection. As the hepatic stage is a bottleneck of the plasmodial infection, liver-selective compounds can be considered crucial for further development of the malaria prophylactics.

590    __

$a NEINDEXOVÁNO

655    _2

$a časopisecké články $7 D016428

700    1_

$a Ritomská, Aneta $u Secondary Metabolites of Plants as Potential Drugs Research Group, Department of Pharmacognosy and Pharmaceutical Botany, Faculty of Pharmacy, Charles University, Heyrovského 1203, 500 05 Hradec Králové, Czech Republic

700    1_

$a Fontinha, Diana $u Prudêncio Lab, Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Av. Prof. Egas Moniz, Edf. Egas Moniz, 1649-028 Lisboa, Portugal $1 https://orcid.org/000000020046648X

700    1_

$a Křoustková, Jana $u Secondary Metabolites of Plants as Potential Drugs Research Group, Department of Pharmacognosy and Pharmaceutical Botany, Faculty of Pharmacy, Charles University, Heyrovského 1203, 500 05 Hradec Králové, Czech Republic

700    1_

$a Suchánková, Daniela $u Secondary Metabolites of Plants as Potential Drugs Research Group, Department of Pharmacognosy and Pharmaceutical Botany, Faculty of Pharmacy, Charles University, Heyrovského 1203, 500 05 Hradec Králové, Czech Republic

700    1_

$a Hošťálková, Anna $u Secondary Metabolites of Plants as Potential Drugs Research Group, Department of Pharmacognosy and Pharmaceutical Botany, Faculty of Pharmacy, Charles University, Heyrovského 1203, 500 05 Hradec Králové, Czech Republic $1 https://orcid.org/0000000332053767 $7 uk20201090163

700    1_

$a Šafratová, Marcela $u Secondary Metabolites of Plants as Potential Drugs Research Group, Department of Pharmacognosy and Pharmaceutical Botany, Faculty of Pharmacy, Charles University, Heyrovského 1203, 500 05 Hradec Králové, Czech Republic

700    1_

$a Kohelová, Eliška $u Secondary Metabolites of Plants as Potential Drugs Research Group, Department of Pharmacognosy and Pharmaceutical Botany, Faculty of Pharmacy, Charles University, Heyrovského 1203, 500 05 Hradec Králové, Czech Republic

700    1_

$a Peřinová, Rozálie $u Secondary Metabolites of Plants as Potential Drugs Research Group, Department of Pharmacognosy and Pharmaceutical Botany, Faculty of Pharmacy, Charles University, Heyrovského 1203, 500 05 Hradec Králové, Czech Republic

700    1_

$a Vrabec, Rudolf $u Secondary Metabolites of Plants as Potential Drugs Research Group, Department of Pharmacognosy and Pharmaceutical Botany, Faculty of Pharmacy, Charles University, Heyrovského 1203, 500 05 Hradec Králové, Czech Republic

700    1_

$a Francisco, Denise $u Prudêncio Lab, Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Av. Prof. Egas Moniz, Edf. Egas Moniz, 1649-028 Lisboa, Portugal $1 https://orcid.org/0000000317637107

700    1_

$a Prudêncio, Miguel $u Prudêncio Lab, Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Av. Prof. Egas Moniz, Edf. Egas Moniz, 1649-028 Lisboa, Portugal $1 https://orcid.org/0000000317466029

700    1_

$a Cahlíková, Lucie $u Secondary Metabolites of Plants as Potential Drugs Research Group, Department of Pharmacognosy and Pharmaceutical Botany, Faculty of Pharmacy, Charles University, Heyrovského 1203, 500 05 Hradec Králové, Czech Republic $1 https://orcid.org/0000000215558870 $7 xx0062498

773    0_

$w MED00186380 $t Pharmaceutics $x 1999-4923 $g Roč. 15, č. 3 (2023)

856    41

$u https://pubmed.ncbi.nlm.nih.gov/36986868 $y Pubmed

910    __

$a ABA008 $b sig $c sign $y p $z 0

990    __

$a 20230413 $b ABA008

991    __

$a 20230421100020 $b ABA008

999    __

$a ok $b bmc $g 1922624 $s 1188860

BAS    __

$a 3

BAS    __

$a PreBMC-PubMed-not-MEDLINE

BMC    __

$a 2023 $b 15 $c 3 $e 20230321 $i 1999-4923 $m Pharmaceutics $n Pharmaceutics $x MED00186380

LZP    __

$a Pubmed-20230413